214833-13-3

Upstream product

• 214833-03-1 2,2,4,4-Tetramethyl-oxazolidine-3-carboxylic acid (1S,3S)-3-dibenzylamino-1-methyl-4-trityloxy-butyl ester 
• 214832-84-5 2,2,4,4-Tetramethyl-oxazolidine-3-carboxylic acid (S)-3-dibenzylamino-4-trityloxy-butyl ester 
• 214832-94-7 (S)-3-Dibenzylamino-4-trityloxy-butan-1-ol 
• 152299-13-3 (2S)-4-{[tert-butyl(dimethyl)silyl]oxy}-2-(dibenzylamino)butan-1-ol 
• 214833-12-2 (2S,4S)-2-Dibenzylamino-pentane-1,4-diol 

Relevant academic research and scientific papers

Monocarbamates, derived from (S)-2-(dibenzylamino)butane-1,4-diol, and the influence of the second O-protecting group on the regioselectivity of deprotonation - Application to the synthesis of the boletus toxin (2S,4S)-γ-hydroxy-norvaline

Differentially protected 1-O- and 4-O-monocarbamates, derived from (S)-2-(dibenzylamino)butane-1,4-diol are prepared and investigated with respect to their capability of being deprotonated and forming the corresponding lithium carbanions. In the 1-O-trity